HomeDealsNegotiationsPolicyPipelineMoneyPeopleDataThe WeekPharmTech 100CompaniesDeal TrackerResearch
Biotech

Editas Medicine, Inc.

1
Articles
Mentioned
Top Role
Mar 28, 2026
First Mention
Mar 28, 2026
Last Mention
0.63
Relevance Score

Coverage Timeline

March 2026
CRISPR in the Real World: Vertex and CRISPR Therapeutics Shake Up Rare Disease Economics with Exa-cel The Week Mentioned
Mar 28, 2026
Small-cap CRISPR players like Intellia, Editas, and Beam are rethinking their business development strategies after exa-cel’s launch.
Related Companies
Beam Therapeutics Inc.
1 shared
Intellia Therapeutics, Inc.
1 shared
Centers for Medicare and Medicaid Services
1 shared
GSK plc
1 shared
Vertex Pharmaceuticals Incorporated
1 shared
Cigna Corporation
1 shared
CRISPR Therapeutics AG
1 shared
Blue Cross Blue Shield
1 shared
Novartis AG
1 shared